Volrustomig
Product Specifications
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation|||Cell Cycle/Checkpoint|||Apoptosis
Bioactivity
Volrustomig is a bi-engineered fragment crystallizable (Fc) domain, a monovalent bispecific IgG1 monoclonal antibody targeting the key immune checkpoint receptors PD-1 and CTLA-4. It boosts T-cell activation and antitumor immunity, making it a promising immunotherapy for various cancers. Molecular weight: 146.77 kDa.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/315447168599064581/T9901A-782
CAS Number
2407760-40-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
